
Teladoc (TDOC) shares are inching up after Citron Research likened them to a “coiled spring” – full of potential, compressed, and ready to surge with right catalyst – in its report on Tuesday.
According to the equity research firm, TDOC shares are worth owning for the long term given the growth potential embedded in its BetterHelp online therapy platform.